CR9468A - Oblea que contiene hormonas esteroides - Google Patents

Oblea que contiene hormonas esteroides

Info

Publication number
CR9468A
CR9468A CR9468A CR9468A CR9468A CR 9468 A CR9468 A CR 9468A CR 9468 A CR9468 A CR 9468A CR 9468 A CR9468 A CR 9468A CR 9468 A CR9468 A CR 9468A
Authority
CR
Costa Rica
Prior art keywords
steroid hormones
oblea
containing steroid
dissolved
released
Prior art date
Application number
CR9468A
Other languages
English (en)
Spanish (es)
Inventor
Krumme Markus
Radlmaier Albert
General Sascha
Dittgen Michael
Jensen Keith
Original Assignee
Bayer Shering Pharma Ag
Lts Lohman Therapie Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36998911&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR9468(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Shering Pharma Ag, Lts Lohman Therapie Systeme Ag filed Critical Bayer Shering Pharma Ag
Publication of CR9468A publication Critical patent/CR9468A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/40—Mineralocorticosteroids, e.g. aldosterone; Drugs increasing or potentiating the activity of mineralocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CR9468A 2005-03-31 2007-10-23 Oblea que contiene hormonas esteroides CR9468A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005015128A DE102005015128B4 (de) 2005-03-31 2005-03-31 Wafer enthaltend Steroidhormone

Publications (1)

Publication Number Publication Date
CR9468A true CR9468A (es) 2008-01-21

Family

ID=36998911

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9468A CR9468A (es) 2005-03-31 2007-10-23 Oblea que contiene hormonas esteroides

Country Status (26)

Country Link
US (2) US9763960B2 (enExample)
EP (1) EP1863444B1 (enExample)
JP (2) JP5843416B2 (enExample)
KR (2) KR101428625B1 (enExample)
CN (2) CN104983669B (enExample)
AR (1) AR054245A1 (enExample)
AU (1) AU2006228820B2 (enExample)
BR (1) BRPI0609601A2 (enExample)
CA (1) CA2598892C (enExample)
CR (1) CR9468A (enExample)
DE (1) DE102005015128B4 (enExample)
DO (1) DOP2006000070A (enExample)
EA (1) EA014183B1 (enExample)
GT (1) GT200600126A (enExample)
IL (1) IL186081A0 (enExample)
MX (1) MX2007012081A (enExample)
NO (1) NO20075404L (enExample)
NZ (1) NZ592882A (enExample)
PE (1) PE20061194A1 (enExample)
SG (1) SG179459A1 (enExample)
SV (1) SV2008002466A (enExample)
TW (1) TWI393576B (enExample)
UA (1) UA92011C2 (enExample)
UY (1) UY29441A1 (enExample)
WO (1) WO2006102990A2 (enExample)
ZA (1) ZA200706116B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2985026T3 (pl) 2005-04-15 2023-02-20 Clarus Therapeutics, Inc. Farmaceutyczne systemy dostarczania leków hydrofobowych i zawierające je kompozycje
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
EA018330B1 (ru) * 2008-02-13 2013-07-30 Байер Интеллекчуал Проперти Гмбх Система доставки лекарственного средства со стабилизирующим эффектом
MX2010008940A (es) * 2008-02-13 2010-10-05 Bayer Schering Pharma Ag Sistemas de administracion de drogas que contienen estradiol.
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
CA2744127A1 (en) * 2008-11-21 2010-05-27 Bayer Schering Pharma Aktiengesellschaft Drug delivery system
CN102933207B (zh) 2009-10-30 2018-02-02 Ix生物医药有限公司 快速溶解固体剂型
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
CA2878680C (en) 2012-07-23 2019-09-17 Crayola, Llc Dissolvable films and methods of using the same
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
HUE072803T2 (hu) * 2018-02-02 2025-12-28 Acerus Biopharma Inc Tesztoszteron terápiás eljárások

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
US4136162A (en) * 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DK0641192T3 (da) * 1992-05-18 1998-03-02 Minnesota Mining & Mfg Anordning til transmucosal lægemiddelafgivelse
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
JP2004502724A (ja) * 2000-07-06 2004-01-29 デルシス　ファーマシューティカル　コーポレイション 増大した安定性を有するヘルスケア製品の製剤化方法
GB0100760D0 (en) * 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
JP2007500729A (ja) * 2003-07-31 2007-01-18 アイバックス コーポレイション 雄性及び雌性の性機能障害の治療方法
AU2004283431B2 (en) * 2003-10-10 2009-09-10 Antares Pharma Ipl Ag Transdermal pharmaceutical formulation for minimizing skin residues

Also Published As

Publication number Publication date
CN104983669A (zh) 2015-10-21
DE102005015128B4 (de) 2008-12-11
AR054245A1 (es) 2007-06-13
US20170348321A1 (en) 2017-12-07
EA200702102A1 (ru) 2008-04-28
AU2006228820A1 (en) 2006-10-05
KR20140063740A (ko) 2014-05-27
UA92011C2 (ru) 2010-09-27
NO20075404L (no) 2007-12-20
KR20080002798A (ko) 2008-01-04
SG179459A1 (en) 2012-04-27
MX2007012081A (es) 2007-11-21
WO2006102990A3 (de) 2007-03-22
TWI393576B (zh) 2013-04-21
AU2006228820B2 (en) 2011-08-25
GT200600126A (es) 2007-03-14
US9763960B2 (en) 2017-09-19
CN104983669B (zh) 2018-05-18
CA2598892C (en) 2014-10-14
KR101428625B1 (ko) 2014-08-13
EP1863444A2 (de) 2007-12-12
DE102005015128A1 (de) 2006-10-05
BRPI0609601A2 (pt) 2010-04-20
JP2008534533A (ja) 2008-08-28
UY29441A1 (es) 2006-10-31
US20060222708A1 (en) 2006-10-05
EP1863444B1 (de) 2015-12-09
JP2013155190A (ja) 2013-08-15
NZ592882A (en) 2012-12-21
IL186081A0 (en) 2008-01-20
SV2008002466A (es) 2008-02-08
CN101132766A (zh) 2008-02-27
DOP2006000070A (es) 2007-08-15
CA2598892A1 (en) 2006-10-05
JP5843416B2 (ja) 2016-01-13
WO2006102990A2 (de) 2006-10-05
PE20061194A1 (es) 2006-11-23
TW200714299A (en) 2007-04-16
EA014183B1 (ru) 2010-10-29
ZA200706116B (en) 2008-11-26

Similar Documents

Publication Publication Date Title
CR9468A (es) Oblea que contiene hormonas esteroides
AR059174A1 (es) Formas farmaceuticas en forma de pelicula para usar en la cavidad bucal (obleas)
EA200870219A1 (ru) Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения
GT200500045A (es) Solidos supersaturados estabilizados de drogas lipofilicas
UY32926A (es) Compuestos como antagonistas de los receptores de ácido lisofosfatídico
AR059358A1 (es) Formulaciones farmaceuticas
NI201000183A (es) Regímenes de dosificación de antiprogestina.
CR20140340A (es) Formas farmacéuticas de dosificación oral resistente a interferencias que comprenden un analgésico opioide
GT200500155A (es) Terapia del càncer resistente al platino
AR078159A1 (es) Composicion que contiene palmitoil-etanolamida ultra-micronizada .metodo. compuesto.forma polimorfica.
MX2009010289A (es) Composiciones para administracion nasal.
AU2008347158A8 (en) Oral pharmaceutical dosage forms
MX2013011336A (es) Composiciones farmaceuticas intranasales de benzodiazepina.
CR11078A (es) Una composicion de liberacion prolongada que comprende un derivado de somatostatina en microparticulas
ECSP10010588A (es) Formulacion de medicamento solida con liberacion retardada
UY29395A1 (es) Formulación de medicamentos conteniendo vardenafilo.
EA201171497A1 (ru) Снижение флуктуаций опиоидов в крови
AR092840A1 (es) Elaboracion de degarelix
UY31128A1 (es) Formulacion de nevirapina de liberacion prolongada
CR10407A (es) Formulacion de medicamento liquida.
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
CR8371A (es) Formulaciones de medicamento que contienen saborizantes con mejores propiedades farmaceuticas
EA201170843A1 (ru) Предварительно спрессованные быстро распадающиеся лекарственные формы соединений с низкой пероральной биодоступностью
CO6331424A2 (es) Formulacion farmaceutica de eprosartan
PE20151432A1 (es) Formulaciones de lorazepam de liberacion sostenida